We are live on ! Find out more
DVC

Deer VII & Co Portfolio holdings

AUM $317M
1-Year Est. Return 30.89%
This Fund
S&P 500
This Quarter Est. Return
-9.46%
1 Year Est. Return
+30.89%
3 Year Est. Return
+241.3%
5 Year Est. Return
+1,036.06%
10 Year Est. Return
–
AUM
$354M
AUM Growth
-$29.3M
Cap. Flow
-$13.8M
Cap. Flow %
-3.88%
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
–
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
TWOU
2U Inc
TWOU
+$36.4M
2
DARE icon
Dare Bioscience
DARE
+$1.08M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$31.1M
2
CRTO icon
Criteo
CRTO
+$17.2M
3
INSM icon
Insmed
INSM
+$2.93M

Sector Composition

Rank Sector Weight
1 Technology 55.5%
2 Communication Services 33.34%
3 Healthcare 11.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WIX icon
1
WIX.com
WIX
$2.15B
$157M 44.43%
7,935,978
– –
CRTO icon
2
Criteo
CRTO
$1.13B
$118M 33.34%
3,498,513
-513,990
-13% -$17.2M
TWOU
3
DELISTED
2U Inc
TWOU
$39.3M 11.08%
+86,487
New +$36.4M
TPST icon
4
Tempest Therapeutics
TPST
$15.4M
$21.9M 6.19%
818
– –
VSTM icon
5
Verastem
VSTM
$530M
$10.8M 3.04%
99,197
– –
XLRN
6
DELISTED
Acceleron Pharma
XLRN
$5.95M 1.68%
175,075
-930,889
-84% -$31.1M
DARE icon
7
Dare Bioscience
DARE
$29.4M
$880K 0.25%
+1,405
New +$1.08M
INSM icon
8
Insmed
INSM
$23.5B
– –
-170,962
Closed -$2.93M

Similar funds

DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
UTC
Unified Trust Company Lexington, Kentucky $339M AUM 28.99% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
OH
Overlook Holdings Tortola, British Virgin Islands $379M AUM 13.2% 1-Year Est. Return

Deer VII & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Deer VII & Co held 8 positions worth $354M, down 7.6% from $384M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Deer VII & Co withdrew a net $13.8M in Q2 2014, closing 1 position and reducing 2 holdings. Its most notable exit was Insmed, an estimated $2.93M position sold in full.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 43% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Deer VII & Co opened a new position in 2U Inc worth $39.3M.

  • Deer VII & Co's largest Q2 2014 buy was 2U Inc: 86,487 shares worth $39.3M.
  • Deer VII & Co's biggest Q2 2014 reduction was Acceleron Pharma, cutting an estimated $31.1M.
  • Deer VII & Co fully exited Insmed in Q2 2014, selling an estimated $2.93M.
  • Deer VII & Co's ten largest holdings make up 100% of its $354M portfolio in Q2 2014.
  • Deer VII & Co opened 2 new positions and closed 1 in Q2 2014.
  • Deer VII & Co's portfolio value fell 7.6% quarter-over-quarter to $354M.

Based on Deer VII & Co's 13F filing for Q2 2014, filed 4 Aug 2014.